(Total Views: 679)
Posted On: 02/24/2018 11:23:48 PM
Post# of 15624
I think that any time you create doubt in the mind of investors you're lucky if the price doesn't drop some. Those who are reading the boards actively now know they're not looking at the company, but those who merely skim may not know what we've found out. Truth is, if these people are nervous they'll sell and that temporarily drops the price. It will come right back up after a little time, as I've said, if it goes low enough, I may add some more, though I really hadn't intended to add more.
I hope I'm wrong, I hope we add support as more people listen to Hirsch's words, but their is still a great deal of mystery in this stock. I believe that if we knew what I characterize as mystery, the stock would be dramatically higher, so I believe it's all good, but they're simply not telling us.
If I could have one piece of information it would be the protocol of the fibromyalgia trial. I believe it's being done with patients with the disease, but don't know that for a fact. If it is, it's truly the first trial where we could clearly say it works in people. I know we'll be doing trials with patients with psoriasis, acne, etc. with the cream, and all sorts of diseases in time with the sublingual tablet, but it will be awhile before we see data from these, the fibromyalgia trial could be our first report of how our drugs do in people with the diseases we're going after.
Gary
I hope I'm wrong, I hope we add support as more people listen to Hirsch's words, but their is still a great deal of mystery in this stock. I believe that if we knew what I characterize as mystery, the stock would be dramatically higher, so I believe it's all good, but they're simply not telling us.
If I could have one piece of information it would be the protocol of the fibromyalgia trial. I believe it's being done with patients with the disease, but don't know that for a fact. If it is, it's truly the first trial where we could clearly say it works in people. I know we'll be doing trials with patients with psoriasis, acne, etc. with the cream, and all sorts of diseases in time with the sublingual tablet, but it will be awhile before we see data from these, the fibromyalgia trial could be our first report of how our drugs do in people with the diseases we're going after.
Gary
(0)
(0)
Scroll down for more posts ▼